Literature DB >> 9195364

Case report: incomplete septal cirrhosis with liver cell dysplasia.

B Le Bail1, P H Bernard, M Hervouet, J Carles, C Balabaud, P Bioulac-Sage.   

Abstract

A 60-year-old woman was transplanted for end-stage alcoholic cirrhosis. The diagnosis of cirrhosis was made 13 years earlier on the basis of features of portal hypertension and a wedge liver biopsy. Liver function tests were subnormal except for a low prothrombin time. Unproven possible alcohol abuse was the only aetiological factor. Her condition remained unchanged until transplantation, despite complete abstinence. Histological examination of the explant showed incomplete septal cirrhosis associated with distal obstructive portal venopathy, cirrhotic nodules predominantly in the subcapsular areas and nodular regenerative hyperplasia with septal fibrosis elsewhere. In addition, there were areas of large and small liver cell dysplasia. This observation shows the difficulty in making a diagnosis of incomplete septal cirrhosis and the hypothetical link between liver cell dysplasia (which has never been reported in incomplete septal cirrhosis but is well known to be associated with hepatocellular carcinoma in cirrhosis) and rare cases of liver adenomas and carcinomas reported in patients presenting with liver vascular disorders.

Entities:  

Mesh:

Year:  1997        PMID: 9195364     DOI: 10.1111/j.1440-1746.1997.tb00419.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  1 in total

1.  Liver Transplantation for Acute Intermittent Porphyria: Biochemical and Pathologic Studies of the Explanted Liver.

Authors:  Makiko Yasuda; Angelika L Erwin; Lawrence U Liu; Manisha Balwani; Brenden Chen; Senkottuvelan Kadirvel; Lin Gan; M Isabel Fiel; Ronald E Gordon; Chunli Yu; Sonia Clavero; Antonios Arvelakis; Hetanshi Naik; L David Martin; John D Phillips; Karl E Anderson; Vaithamanithi M Sadagoparamanujam; Sander S Florman; Robert J Desnick
Journal:  Mol Med       Date:  2015-06-05       Impact factor: 6.354

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.